SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-027924
Filing Date
2013-05-10
Accepted
2013-05-10 16:07:39
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v342985_10q.htm 10-Q 278499
2 EXHIBIT 31.1 v342985_ex31-1.htm EX-31.1 8064
3 EXHIBIT 31.2 v342985_ex31-2.htm EX-31.2 8031
4 EXHIBIT 32.1 v342985_ex32-1.htm EX-32.1 3879
5 EXHIBIT 32.2 v342985_ex32-2.htm EX-32.2 3676
  Complete submission text file 0001144204-13-027924.txt   2668457

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vtus-20130331.xml EX-101.INS 225873
7 XBRL TAXONOMY EXTENSION SCHEMA vtus-20130331.xsd EX-101.SCH 49395
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtus-20130331_cal.xml EX-101.CAL 12453
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtus-20130331_def.xml EX-101.DEF 224750
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtus-20130331_lab.xml EX-101.LAB 392568
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtus-20130331_pre.xml EX-101.PRE 249333
Mailing Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013
Business Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013 (212) 554-4388
VENTRUS BIOSCIENCES INC (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 13833493
SIC: 2834 Pharmaceutical Preparations